Cargando…
A study on the evaluation method and recent clinical efficacy of bevacizumab on the treatment of radiation cerebral necrosis
In order to investigate the efficacy of bevacizumab on the treatment of radiation cerebral necrosis, patients who were diagnosed with radiation cerebral necrosis by imaging after stereotactic radiotherapy were collected. Bevacizumab was applied at a dose of 5 mg/kg once every three weeks at least th...
Autores principales: | Zhuang, Hongqing, Yuan, Xiangkun, Zheng, Yi, Li, Xubin, Chang, Joe Y., Wang, Junjie, Wang, Xiaoguang, Yuan, Zhiyong, Wang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4828710/ https://www.ncbi.nlm.nih.gov/pubmed/27067388 http://dx.doi.org/10.1038/srep24364 |
Ejemplares similares
-
Exploration of the recurrence in radiation brain necrosis after bevacizumab discontinuation
por: Zhuang, Hongqing, et al.
Publicado: (2016) -
Acquired-resistance of bevacizumab treatment for radiation brain necrosis: a case report
por: Zhuang, Hongqing, et al.
Publicado: (2016) -
Bevacizumab treatment for radiation brain necrosis: mechanism, efficacy and issues
por: Zhuang, Hongqing, et al.
Publicado: (2019) -
Analysis of risk and predictors of brain radiation necrosis after radiosurgery
por: Zhuang, Hongqing, et al.
Publicado: (2015) -
Ultra-Low-Dose Bevacizumab For Cerebral Radiation Necrosis: A Prospective Phase II Clinical Study
por: Zhuang, Hongqing, et al.
Publicado: (2019)